Skip to main content
. Author manuscript; available in PMC: 2020 Jul 27.
Published in final edited form as: J Urol. 2019 Oct 9;203(4):699–705. doi: 10.1097/JU.0000000000000587

Figure 3.

Figure 3.

Cancer detection rate for any cancer, clinically-significant prostate cancer, and GS≥7 between free-hand versus 3D template mapping biopsy cohorts. Template mapping biopsy detected more cancers overall and more clinically-significant cancers, but did not detect more GG≥2 cancers.